Quest Diagnostics (DGX) Operating Margin (2008 - 2026)
Quest Diagnostics (DGX) operating margin from Jun 30, 2008 to Mar 31, 2026. The current Quest Diagnostics (DGX) operating margin is 13.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Quest Diagnostics (DGX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 14.10% | +3.42% |
| 2024 | 13.63% | -0.04% |
| 2023 | 13.64% | -5.60% |
| 2022 | 14.45% | -34.53% |
| 2021 | 22.07% | +5.67% |
| 2020 | 20.89% | +31.08% |
| 2019 | 15.93% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 14.62% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 15.74% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | 17.70% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2016 | 0.00% | -100.00% |
| 2015 | 18.67% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2015 | 0.00% | -100.00% |
| 2014 | 13.22% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2014 | 0.00% | -100.00% |
| 2013 | 20.64% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2013 | 0.00% | -100.00% |
| 2012 | 16.27% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | 13.35% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2010 | 17.68% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | N/A |
| 2010 | 0.00% | -100.00% |
| 2009 | 18.23% | N/A |
| 2009 | 0.00% | N/A |
| 2009 | 0.00% | N/A |
| 2009 | 0.00% | -100.00% |
| 2008 | 16.86% | +3.59% |
| 2007 | 16.28% | N/A |
Comparison Quest Diagnostics (DGX) operating margin with competitors
Quest Diagnostics (DGX) operating margin is 13.78%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | +130.58% |
| SHC | Sotera Health Company | 28.16% | +104.32% |
| MTD | Mettler-Toledo International Inc | 26.00% | +88.65% |
| QGEN | Qiagen NV | 22.29% | +61.73% |
| MEDP | Medpace Holdings Inc | 20.03% | +45.33% |
| A | Agilent Technologies Inc | 19.63% | +42.43% |
| ILMN | Illumina Inc | 19.16% | +39.02% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | +22.84% |
| BLLN | Billiontoone Inc - Class A | 16.45% | +19.36% |
| VCYT | Veracyte Inc | 16.28% | +18.12% |
| IQV | IQVIA Holdings Inc | 12.38% | -10.18% |
| CRL | Charles River Laboratories International Inc | 12.04% | -12.64% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -21.93% |
| RVTY | Revvity Inc | 10.67% | -22.58% |
| ICLR | Icon Plc | 5.37% | -61.04% |
| CDNA | Caredx Inc | 1.02% | -92.60% |